Clinical Science
Australian & New Zealand Obesity Society 2016 Annual Scientific Meeting
Days
Wednesday, 19th October
Thursday, 20th October
Friday, 21st October
Tracks
Public Health
Clinical Science
Basic Science
Search
Speakers
Concurrent session: Unspoken Dysfunctions in Obesity
10:30AM - 12:30PM
Wednesday, 19th October
P7
Chairs: Claire Madigan & Jerry Greenfield
Invited talk: Executive dysfunction in obese individuals
-
Evelyn Smith
Invited talk: Interactions between insulin resistance and bone health
-
Katherine Tonks
Invited talk: Is the increased exposure to antidepressants a key contributor to the obesity pandemic?
-
Julio Licinio
Impact of energy restriction on eating behaviour traits in individuals with low satiety efficiency
-
Vicky Drapeau
The effects of increasing dietary protein during energy balance and energy restriction on homeostatic and hedonic processes
-
Leonie Ruddick-Collins
Concurrent session: Outwitting the Obesity / Diabetes Connection
10:30AM - 12:30PM
Thursday, 20th October
P7
Chairs: Cilla Haywood & Dorit Samocha-Bonet
Invited talk: Diabetes Surgery - has the time arrived?
-
John Dixon
Invited talk: Prediabetes Phenotypes improve Prediction and Prevention of Type 2 Diabetes
-
Jenny Gunton
Invited talk: Metabolic Syndrome: Sympathetic (Neural) Perspectives
-
Nora Straznicky
Insulin-sensitive overweight/obese individuals remain as insulin sensitive and normotensive as lean subjects over 6 years
-
Alice Tang
Effects of a large breakfast versus large dinner on 24-h blood glucose profiles during a day of prolonged sedentary behaviour
-
Evelyn B Parr
Concurrent session: Manipulating meal size and composition for health
5:00PM - 6:00PM
Thursday, 20th October
P7
Chairs: Tanya Little & Andrew McAinch
Oleoylethanolamine and endocannabinoid responses to intraduodenal lipid infusion in humans: relationships with BMI and energy intake
-
Tanya J Little
Weight loss and tissue remodelling following 8-week calorie restriction or intermittent fasting in females who are overweight and obese
-
Bo Liu
The influence of meals containing differing fatty acid compositions on appetite parameters in overweight and obese individuals
-
Shaan S Naughton
Cognitive performance in normal weight and obese young women and its association with omega-3 PUFA
-
Helen Parker
Concurrent session - Therapeutic and lifestyle management of obesity
10:30AM - 12:30PM
Friday, 21st October
P7
Chair: Priya Sumithran
Invited talk: Treating Diabetes and Obesity Using the Gut Microbiome Involves Dietary Diversity
-
Frank Greenway
Early weight loss responders to liraglutide 3.0 mg had greater weight loss, regression to normoglycaemia, and reduced T2D development at 3 years vs early non-responders: SCALE Obesity and Prediabetes
-
Trisha O’Moore-Sullivan
Liraglutide 3.0 mg reduces body weight and improves cardiometabolic risk factors in adults with obesity or overweight, but without diabetes: the SCALE Obesity and Prediabetes randomised, double-blind, placebo-controlled 3-year trial
-
Tania Markovic
Effects of exercise on appetite and gut hormones: implications for weight management.
-
Shelley E Keating
Tertiary level management of severe paediatric obesity-Interventions must focus on younger children and address attrition rates.
-
Kerryn W Chisholm
Metabolic and nutrition-related effects of a duodenal-jejunal bypass sleeve in patients with obesity and Type II diabetes: preliminary results of a pilot study
-
Jessica McMaster
Do making habits or breaking habits influence weight loss and weight loss maintenance? A randomised controlled trial.
-
Gina Cleo